The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry

Author:

Tomasoni Daniela12,Vitale Cristiana3,Guidetti Federica2,Benson Lina2,Braunschweig Frieder24,Dahlström Ulf5,Melin Michael46,Rosano Giuseppe M.C.78,Lund Lars H.24,Metra Marco1,Savarese Gianluigi24ORCID

Affiliation:

1. Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties Radiological Sciences, and Public Health, University of Brescia Brescia Italy

2. Division of Cardiology, Department of Medicine Karolinska Institutet Stockholm Sweden

3. Department of Cardiology St George's Hospital London UK

4. Heart, Vascular and Neuro Theme, Karolinska University Hospital Stockholm Sweden

5. Department of Cardiology and Department of Health Medicine and Caring Sciences, Linköping University Linköping Sweden

6. Department of Laboratory Medicine Section of Clinical Physiology, Karolinska Institutet Huddinge Sweden

7. San Raffaele, Cassino, Italy

8. St George's University Hospital London UK

Abstract

ABSTRACTAimsThe aim of this analysis was to provide data on the overall comorbidity burden, both cardiovascular (CV) and non‐CV, in a large real‐world heart failure (HF) population across the ejection fraction (EF).Methods and resultsPatients with HF from the Swedish HF Registry between 2000 and 2021 were included. Of 91 463 patients (median age 76 years [interquartile range 67–82]), 98% had at least one among the 17 explored comorbidities (94% at least one CV and 85% at least one non‐CV comorbidity). All comorbidities, except for coronary artery disease (CAD), were more frequent in HF with preserved EF (HFpEF). Patients with multiple comorbidities were older, more likely female, inpatients, with HFpEF, worse New York Heart Association class and higher N‐terminal pro‐B‐type natriuretic peptide levels. In a multivariable Cox model, 12 comorbidities were independently associated with a higher risk of death from any cause. The highest risk was associated with dementia (hazard ratio [HR] 1.55, 95% confidence interval [CI] 1.45–1.65), chronic kidney disease (HR 1.37, 95% CI 1.34–1.41), chronic obstructive pulmonary disease (HR 1.32, 95% CI 1.28–1.35). Obesity was associated with a lower risk of all‐cause death (HR 0.81, 95% CI 0.79–0.84). CAD and valvular heart disease were associated with a higher risk of all‐cause and CV mortality, but not non‐CV mortality, whereas cancer and musculo‐skeletal disease increased the risk of non‐CV mortality. A significant interaction with EF was observed for several comorbidities. Occurrence of CV and non‐CV outcomes was related to the number of CV and non‐CV comorbidities, respectively.ConclusionThe burden of both CV and non‐CV comorbidities was high in HF regardless of EF, but overall higher in HFpEF. Multimorbidity was associated with a high risk of death with a different burden on CV or non‐CV outcomes.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3